Last reviewed · How we verify
NCT05611814
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
NA trial testing Osteopathic Manipulative Treatment in Motion Sickness in 12 participants. Completed in 24 September 2022.
24 September 2022
Quick facts
| Lead sponsor | United States Army Aeromedical Research Laboratory |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 12 |
| Start date | 24 September 2022 |
| Primary completion | 24 September 2022 |
| Estimated completion | 24 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Osteopathic Manipulative Treatment
- Sham treatment — full drug profile →
Conditions studied
- Motion Sickness — all drugs for Motion Sickness →
Sponsor
United States Army Aeromedical Research Laboratory
Who can join
19 and older, any sex, with Motion Sickness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Motion sickness directly impacts the readiness of the Army's aviation units. Severe motion sickness results in the dismissal of pilot and air crew candidates during initial training, while minor to moderate symptoms can be distracting during flight. The current medications on the market that target motion sickness symptoms are prohibited for use before flight. Osteopathic Manipulative Techniques are a low to no cost option, which lacks side effects, that allows Doctor of Osteopathic Medicine flight surgeons the opportunity to treat crew members without the use of pharmaceuticals. If effective, these techniques could be used to ensure aircrew readiness. Given the paucity of research on such a technique, a small, pilot study was conducted to demonstrate potential for such an approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05611814
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Osteopathic Manipulative Treatment
Trials testing the same drug.
- NCT07216300 — Osteopathic Manipulative Treatment for Pitch Performance in Baseball Players: A Study on Shoulder and Hip Interventions · NA · enrolling by invitation
- NCT06671600 — Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects · NA · not yet recruiting
- NCT06891248 — The Utility of Osteopathic Manipulative Medicine in Weaning Patients from the Ventilator Pilot Trial · NA · not yet recruiting
- NCT06533345 — VCOM Pain Free Research Collaborative · NA · recruiting
- NCT06570395 — Osteopathic Manipulative Treatment in the Third Trimester of Pregnancy · terminated
Other recruiting trials for Motion Sickness
Currently open trials in the same condition.
- NCT06892340 — Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation · NA · recruiting
- NCT06138613 — Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness · Phase 3 · active not recruiting
- NCT05622344 — StableEyes With Active Neurofeedback · NA · recruiting
Other United States Army Aeromedical Research Laboratory trials
Trials by the same sponsor.
- NCT04697901 — Sustaining Aviator Performance During Extended Operational Flight · NA · completed
- NCT04155333 — Effects of Non-Invasive Brain Stimulation on Soldiers' Cognitive and Functional Performance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05611814 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by United States Army Aeromedical Research Laboratory
- Last refreshed: 10 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05611814.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing